메뉴 건너뛰기




Volumn 4, Issue 1, 2012, Pages

Outcome of antifungal combination therapy for invasive mold infections in hematological patients is independent of the chosen combination

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CANDIN; CASPOFUNGIN; CREATININE; FLUCONAZOLE; ITRACONAZOLE; LIVER ENZYME; POSACONAZOLE; TRIAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

EID: 84857469187     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2012.011     Document Type: Article
Times cited : (16)

References (40)
  • 1
    • 0037114705 scopus 로고    scopus 로고
    • Invasive aspergillosis in allogeneic stem cell transplantation recipients; Changes in epidemiology and risk factors
    • PMid:12393425
    • Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplantation recipients; Changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366. http://dx.doi.org/10.1182/blood-2002-05-1496 PMid:12393425
    • (2002) Blood , vol.100 , pp. 4358-4366
    • Marr, K.A.1    Carter, R.A.2    Boeckh, M.3    Martin, P.4    Corey, L.5
  • 2
    • 33751055610 scopus 로고    scopus 로고
    • Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes
    • Sanz MA, Jarque I, Salavert M, Pemán J. Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes. Clin Microbiol Infect 2006; 12 (Suppl 7): 2-6. http://dx.doi.org/10.1111/j.1469-0691.2006.01602.x
    • (2006) Clin Microbiol Infect , vol.12 , Issue.SUPPL. 7 , pp. 2-6
    • Sanz, M.A.1    Jarque, I.2    Salavert, M.3    Pemán, J.4
  • 3
    • 58749083534 scopus 로고    scopus 로고
    • Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry
    • PMid:19115967
    • Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009;48:265-73. http://dx.doi.org/10.1086/595846 PMid:19115967
    • (2009) Clin Infect Dis , vol.48 , pp. 265-273
    • Neofytos, D.1    Horn, D.2    Anaissie, E.3    Steinbach, W.4    Olyaei, A.5    Fishman, J.6    Pfaller, M.7    Chang, C.8    Webster, K.9    Marr, K.10
  • 4
    • 0035109799 scopus 로고    scopus 로고
    • Aspergillosis case-fatality rate: systematic review of the literature
    • PMid:11170942
    • Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-366. http://dx.doi.org/10.1086/318483 PMid:11170942
    • (2001) Clin Infect Dis , vol.32 , pp. 358-366
    • Lin, S.J.1    Schranz, J.2    Teutsch, S.M.3
  • 5
    • 33846934215 scopus 로고    scopus 로고
    • Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality
    • PMid:17243056
    • Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007;44:531-540. http://dx.doi.org/10.1086/510592 PMid:17243056
    • (2007) Clin Infect Dis , vol.44 , pp. 531-540
    • Upton, A.1    Kirby, K.A.2    Carpenter, P.3    Boeckh, M.4    Marr, K.A.5
  • 7
    • 0033545538 scopus 로고    scopus 로고
    • National Institute of Allergy and Infectious Diseases Mycoses Study Group. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
    • PMid:10072411
    • Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 1999; 340: 764-771. http://dx.doi.org/10.1056/NEJM199903113401004 PMid:10072411
    • (1999) N Engl J Med , vol.340 , pp. 764-771
    • Walsh, T.J.1    Finberg, R.W.2    Arndt, C.3    Hiemenz, J.4    Schwartz, C.5    Bodensteiner, D.6    Pappas, P.7    Seibel, N.8    Greenberg, R.N.9    Dummer, S.10    Schuster, M.11    Holcenberg, J.S.12
  • 10
    • 27444447144 scopus 로고    scopus 로고
    • Galactomannan and computer tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study
    • PMid:16206097
    • Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J. Galactomannan and computer tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study. Clin Infect Dis 2005; 41: 1242-1250. http://dx.doi.org/10.1086/496927 PMid:16206097
    • (2005) Clin Infect Dis , vol.41 , pp. 1242-1250
    • Maertens, J.1    Theunissen, K.2    Verhoef, G.3    Verschakelen, J.4    Lagrou, K.5    Verbeken, E.6    Wilmer, A.7    Verhaegen, J.8    Boogaerts, M.9    Van Eldere, J.10
  • 14
    • 0037736664 scopus 로고    scopus 로고
    • Intravenous and oral itraconazole versus intravenous and oral fluconazole for longterm antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients: a multicenter, radomized trial
    • PMid:12729424
    • Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC. Intravenous and oral itraconazole versus intravenous and oral fluconazole for longterm antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients: a multicenter, radomized trial. Ann Intern Med 2003; 138: 705-713. PMid:12729424
    • (2003) Ann Intern Med , vol.138 , pp. 705-713
    • Winston, D.J.1    Maziarz, R.T.2    Chandrasekar, P.H.3    Lazarus, H.M.4    Goldman, M.5    Blumer, J.L.6    Leitz, G.J.7    Territo, M.C.8
  • 15
    • 33745258668 scopus 로고    scopus 로고
    • Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis
    • PMid:16626917
    • Siwek GT, Pfaller MA, Polgreen PM, Cobb S, Hoth P, Magalheas-Silverman M, Diekema DJ. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. Diagn Microbiol Infect Dis 2006; 55: 209-212. http://dx.doi.org/10.1016/j.diagmicrobio.2006.01.018 PMid:16626917
    • (2006) Diagn Microbiol Infect Dis , vol.55 , pp. 209-212
    • Siwek, G.T.1    Pfaller, M.A.2    Polgreen, P.M.3    Cobb, S.4    Hoth, P.5    Magalheas-Silverman, M.6    Diekema, D.J.7
  • 17
    • 76249128351 scopus 로고    scopus 로고
    • Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia
    • PMid:19878274
    • Torres A, Serrano J, Rojas R, Martín V, Martín C, Tabares S, Molina JR, Capote M, Martínez F, Gómez P, Sánchez-García J. Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia. Eur J Haematol 2009; 84: 271-273. http://dx.doi.org/10.1111/j.1600-0609.2009.01367.x PMid:19878274
    • (2009) Eur J Haematol , vol.84 , pp. 271-273
    • Torres, A.1    Serrano, J.2    Rojas, R.3    Martín, V.4    Martín, C.5    Tabares, S.6    Molina, J.R.7    Capote, M.8    Martínez, F.9    Gómez, P.10    Sánchez-García, J.11
  • 21
    • 84857466597 scopus 로고    scopus 로고
    • Efficacy of posaconazole (POS) vs standard therapy and safety of POS in hematopoietic stem cell transplant (HSCT) recipients vs other patients with aspergillosis
    • Van Burik JA, Perfect J, Louie A, Graybill JR, Pedicone L, Raad II. Efficacy of posaconazole (POS) vs standard therapy and safety of POS in hematopoietic stem cell transplant (HSCT) recipients vs other patients with aspergillosis. Biol Blood Marrow Transplant 2006; 12 (Suppl 1): 137. http://dx.doi.org/10.1016/j.bbmt.2005.11.420
    • (2006) Biol Blood Marrow Transplant , vol.12 , Issue.SUPPL. 1 , pp. 137
    • Van Burik, J.A.1    Perfect, J.2    Louie, A.3    Graybill, J.R.4    Pedicone, L.5    Raad, I.I.6
  • 23
    • 33748569923 scopus 로고    scopus 로고
    • Flynn PM, van Burik JA, Buell DN, Patterson TF. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
    • PMid:16678903
    • Denning DW, Marr KA, Lau WM, Facklam DP, Ratanatharathorn V, Becker C, Ullmann AJ, Seibel NL, Flynn PM, van Burik JA, Buell DN, Patterson TF. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. J Infect. 2006; 53: 337-349. http://dx.doi.org/10.1016/j.jinf.2006.03.003 PMid:16678903
    • (2006) J Infect , vol.53 , pp. 337-349
    • Denning, D.W.1    Marr, K.A.2    Lau, W.M.3    Facklam, D.P.4    Ratanatharathorn, V.5    Becker, C.6    Ullmann, A.J.7    Seibel, N.L.8
  • 24
    • 0037669567 scopus 로고    scopus 로고
    • Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
    • PMid:12872348
    • Kontoyiannis DP, Hachem R, Lewis RE, Rivero GA, Torres HA, Thornby J, Champlin R, Kantarjian H, Bodey GP, Raad II. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer 2003; 98: 292-299. http://dx.doi.org/10.1002/cncr.11479 PMid:12872348
    • (2003) Cancer , vol.98 , pp. 292-299
    • Kontoyiannis, D.P.1    Hachem, R.2    Lewis, R.E.3    Rivero, G.A.4    Torres, H.A.5    Thornby, J.6    Champlin, R.7    Kantarjian, H.8    Bodey, G.P.9    Raad, I.I.10
  • 26
    • 4544236836 scopus 로고    scopus 로고
    • Combination antifungal therapy for invasive aspergillosis
    • PMid:15472810
    • Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004; 39: 797-802. http://dx.doi.org/10.1086/423380 PMid:15472810
    • (2004) Clin Infect Dis , vol.39 , pp. 797-802
    • Marr, K.A.1    Boeckh, M.2    Carter, R.A.3    Kim, H.W.4    Corey, L.5
  • 30
    • 53649100394 scopus 로고    scopus 로고
    • A clinical cohort trial of antifungal combination therapy: Efficacy and toxicity in hematological cancer patients
    • PMid:18641986
    • Rieger CT, Ostermann H, Kolb HJ, Fiegl M, Huppmann S, Morgenstern N, Tischer J. A clinical cohort trial of antifungal combination therapy: Efficacy and toxicity in hematological cancer patients. Ann Hematol 2008; 87: 915-922. http://dx.doi.org/10.1007/s00277-008-0534-4 PMid:18641986
    • (2008) Ann Hematol , vol.87 , pp. 915-922
    • Rieger, C.T.1    Ostermann, H.2    Kolb, H.J.3    Fiegl, M.4    Huppmann, S.5    Morgenstern, N.6    Tischer, J.7
  • 31
    • 37049003816 scopus 로고    scopus 로고
    • Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies. A randomized pilot study (Combistrat trials)
    • PMid:17941026
    • Caillot D, Thiebaut A, Herbrecht R, de Botton S, Pigneux A, Bernard F, Larché J, Monchecourt F, Alfandari S, Mahi L. Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies. A randomized pilot study (Combistrat trials). Cancer 2007; 110: 2740-2746. http://dx.doi.org/10.1002/cncr.23109 PMid:17941026
    • (2007) Cancer , vol.110 , pp. 2740-2746
    • Caillot, D.1    Thiebaut, A.2    Herbrecht, R.3    de Botton, S.4    Pigneux, A.5    Bernard, F.6    Larché, J.7    Monchecourt, F.8    Alfandari, S.9    Mahi, L.10
  • 32
    • 79952190110 scopus 로고    scopus 로고
    • Use of antifungal combination therapy: agents, order, and timing
    • PMid:20574543 PMCid:2889487
    • Johnson MD, Perfect JR. Use of antifungal combination therapy: agents, order, and timing. Curr Fungal Infect Rep. 2010;4:87-95. http://dx.doi.org/10.1007/s12281-010-0018-6 PMid:20574543 PMCid:2889487
    • (2010) Curr Fungal Infect Rep , vol.4 , pp. 87-95
    • Johnson, M.D.1    Perfect, J.R.2
  • 35
    • 0029095282 scopus 로고
    • Use of amphotericin B with azole antifungal drugs: what are we doing?
    • PMid:8540690 PMCid:162855
    • Sugar AM. Use of amphotericin B with azole antifungal drugs: what are we doing? Antimicrob Agents Chemother. 1995; 39:1907-1912. PMid:8540690 PMCid:162855
    • (1995) Antimicrob Agents Chemother , vol.39 , pp. 1907-1912
    • Sugar, A.M.1
  • 36
    • 0026530435 scopus 로고
    • In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents
    • Denning DW, Hanson LH, Perlman AM, Stevens DA. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis 1992; 15: 21-34. http://dx.doi.org/10.1016/0732-8893(92)90053-V
    • (1992) Diagn Microbiol Infect Dis , vol.15 , pp. 21-34
    • Denning, D.W.1    Hanson, L.H.2    Perlman, A.M.3    Stevens, D.A.4
  • 37
    • 35349019258 scopus 로고    scopus 로고
    • Combination antifungals: an update
    • PMid:17914921
    • Segal BH, Steinbach WJ. Combination antifungals: an update. Expert Rev Anti Infect Ther 2007; 5: 883-892. http://dx.doi.org/10.1586/14787210.5.5.883 PMid:17914921
    • (2007) Expert Rev Anti Infect Ther , vol.5 , pp. 883-892
    • Segal, B.H.1    Steinbach, W.J.2
  • 38
    • 77950363815 scopus 로고    scopus 로고
    • Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B
    • PMid:19887460
    • Cornely OA, Maertens J, Bresnik M, Ullmann AJ, Ebrahimi R, Herbrecht R. Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B. J Antimicrob Chemother. 2010;65:114-117. http://dx.doi.org/10.1093/jac/dkp397 PMid:19887460
    • (2010) J Antimicrob Chemother , vol.65 , pp. 114-117
    • Cornely, O.A.1    Maertens, J.2    Bresnik, M.3    Ullmann, A.J.4    Ebrahimi, R.5    Herbrecht, R.6
  • 40
    • 58149120831 scopus 로고    scopus 로고
    • Granulocyte transfusion therapy: a new era?
    • PMid:19057197 PMCid:2674763
    • Dale DC, Price TH. Granulocyte transfusion therapy: a new era? Curr Opin Hematol 2009;16:1-2. http://dx.doi.org/10.1097/MOH.0b013e32831d7953 PMid:19057197 PMCid:2674763
    • (2009) Curr Opin Hematol , vol.16 , pp. 1-2
    • Dale, D.C.1    Price, T.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.